R
ight atrial (RA) enlargement is a common finding in patients with pulmonary arterial hypertension (PAH). 1, 2 Consistent with this, RA size has been demonstrated to be a predictor of mortality or transplantation in this group, [3] [4] [5] but atrial enlargement may not occur in a symmetrical uniform fashion. Atrial function is complex and has several components, consisting of a reservoir phase during atrial filling, a conduit phase during passive emptying of the atrium into the ventricle, and a pump phase during atrial systole. 6 Coordination of these phasic functions plays an important role for the maintenance of overall cardiac function. 7 In this context, there has been growing interest in markers of RA myocardial dysfunction that might help in early disease stratification before significant RA remodeling. Two-dimensional speckle-tracking echocardiography (STE) has been shown to be feasible for investigating RA function. 8 Recently, Querejeta Roca et al 9 found that RA function by STE is impaired in PAH independent of RA size or pressure. Therefore, the objective of our study was to explore the feasibility of strain-based measures of RA dysfunction and validate them by assessing their prognostic role, independent of RA size in study subjects with PAH.
METHODS

Study Design
The data, methods used in the analysis, and materials used to conduct this study will be made available to any researcher for purposes of reproducing the results or replicating the procedure by emailing the corresponding author (S.R.). The study was designed as a prospective observational cohort study. We enrolled study subjects with known or suspected pulmonary hypertension (PH), referred from the Duke Pulmonary Vascular Disease Center to the Duke Cardiac Diagnostic Unit for a clinically indicated transthoracic echocardiography.
Study Subjects and Data Collection
Study subjects were prospectively enrolled from 2010 to 2014. Inclusion criteria included mean pulmonary artery pressure ≥25 mm Hg at rest or right ventricular systolic pressure >40 mm Hg and suspected diagnosis of PH. In addition, PH diagnosis was confirmed by right heart catheterization. Study subjects with significant arrhythmia were excluded from the study. The study protocol was approved by the institutional review board, and all patients provided written informed consent, which included consent for the transthoracic echocardiography analysis.
Standard Echocardiography Methods
For RA STE analysis, all images were obtained at a frame rate of 50 to 60 frames per second, and 3 consecutive cardiac cycles were recorded. Right ventricle (RV) measures were performed, including tricuspid annular plane systolic excursion, tricuspid regurgitation severity, inferior vena cava diameter, RV fractional area change, and RV global longitudinal strain. Left ventricular ejection fraction was also assessed using Simpson's biplane method. All measurements were conducted in accordance with American Society of Echocardiography recommendations. 10 
Speckle-Tracking Strain and Strain Rate Analysis
Studies were uploaded to the vendor-independent TomTec image arena module (REF-Version 4.6 software, Munich, Germany). STE longitudinal strain (LS) and strain rate (SR) were performed offline in all studies with adequate image quality. RA STE inadequate quality was defined as poor visualization or poor tracking of >1 atrial segments, segment dropout, missing view, or significant foreshortening of the RV or RA (4 studies were excluded because of this). RV global longitudinal strain was also measured, the endocardial border was manually traced in end systole, and the software automatically traced a region of interest including the entire myocardium. The RV free wall and septal wall segments were averaged for RV global longitudinal strain and adjusted to the pulmonary valve closure time.
To generate RA LS and SR curves, the RA endocardial border was manually traced at ventricular end systole in the apical 4-chamber view in each patient; the software divided the RA into 3 separate segments (RA lateral wall, RA roof, and RA septal wall). The RA was traced starting at the lateral tricuspid valve annulus, along the endocardial border of the RA lateral wall, RA roof, RA septal wall, and ending at the septal tricuspid valve annulus. RA LS and SR curves were generated, tracking evaluated, and the region of interest generated was subsequently adjusted to include the full thickness of the RA myocardium. Therefore, in our study, the R wave (QRS complex) was the zero reference, and all strain values were positive ( Figure 1 ).
CLINICAL PERSPECTIVE
The right atrium (RA) is a simpler geometric structure and easier to noninvasively measure than the right ventricle. Here, we prospectively studied the feasibility and prognostic value of RA function using speckle-tracking echocardiography independent of its associations with RA size in patients with pulmonary hypertension. A total of 63 subjects had complete speckle-tracking echocardiography and were included in the final analysis. After multivariable adjustment for age, gender, and left atrium size, peak longitudinal strain, peak active contraction strain, and peak early diastolic strain rate were significantly associated with increased risk of the composite outcome (P=0.0005, P=0.0167, and P=0.0054, respectively). RA dysfunction was associated with lower event-free survival in pulmonary arterial hypertension. RA reservoir, conduit, and active contraction function are independent predictors of mortality and hospitalizations in pulmonary arterial hypertension. Given these findings, RA speckle-tracking echocardiography may be an important tool to risk stratify patients with pulmonary arterial hypertension.
Using STE, the 3 phases of RA function were measured: (1) reservoir function (peak LS [PLS] , peak systolic SR [PSSR] with the time to PLS and to PSSR); (2) RA conduit function (peak early diastolic SR [PEDSR] , with time to PEDSR); and (3) RA active contraction function (peak active contraction strain [PACS] , peak contraction SR [PCSR] , with the time to PACS and to PCSR) ( Figure 1 ). All measurements were performed by a single expert strain investigator (F.A.) blinded to clinical status. A second reader measured key LS and SR measurements on a randomly selected subset (20%) of the cohort to generate inter-rater variability results. 
Clinical Data
For all study subjects enrolled in this study, we collected the following data: demographics, World Health Organization functional class, comorbidities, medications, vital signs, Figure 1 . Right atrial (RA) phasic function strain and strain rate speckle-tracking strain analysis. A, RA strain rate; B, RA strain; and C, RA volumes: (1) peak longitudinal strain (PLS); (2) time to PLS; (3) peak active contraction strain (PACS); (4) time to PACS; (5) peak systolic strain rate (PSSR); (6) time to PSSR; (7) peak diastolic strain rate (PEDSR); (8) time to PEDSR; (9) peak contraction strain rate (PCSR); (10) time to PCSR. R wave (QRS complex) was the zero reference, and all strain values were positive. body mass index, and laboratory data including NT-proBNP (N-terminal pro-B-type natriuretic peptide), 6-minute walk distance, death and hospitalizations. Study participants also underwent right heart catheterization; the following invasive hemodynamic measurements were included: cardiac output/ cardiac index, left atrial pressure, mean pulmonary artery pressure, pulmonary vascular resistance, RA pressure, and pulmonary capillary wedge pressure.
Outcome
The primary end point was a combined outcome of composite of hospitalization or death. Date of last followup was defined as the date of death or last contact from the Duke University Medical Center administrative data sources. Mortality from the Social Security Death Master Files through October 2017 was incorporated into administrative data sources at Duke and accessed for ascertainment of the end point.
Statistical Analysis
To assess the strength of the absolute agreement between observers, the interclass correlation coefficient was used based on a 2-way random effects analysis-of-variance model. High agreement is evidenced by a high interclass correlation coefficient (close to 1). Baseline characteristics were described using mean, SD, median, and interquartile ranges for continuous variables and percentages for categorical variables. In our study, PLS and PACS were dichotomized at cutoff values of 25% and 13%, respectively, for baseline table stratification. P values for differences in patient groups were generated using a Fisher Exact or χ 2 test for categorical variables and Wilcoxon rank-sum testing for continuous variables, based on appropriateness. Cumulative event rates were calculated according to the Kaplan-Meier method, with all event or censoring times measured from the date of echocardiography. The significance of differences in the primary end point between groups was assessed with the use of the log-rank test. Cox proportional hazards models were examined to assess the relationship between RA function measures and the composite outcome, time to death, or hospitalization. Linearity of continuous measures was examined using cubic spline polynomials. Variable transformations were determined when needed to satisfy the linearity assumption of the Cox models. Both unadjusted and adjusted relationships with outcome were examined for continuous RA measures. Stratification for Kaplan-Meier graphs is provided for illustrative purposes, stratifying risk at the median values for RA function (Figure 2A and 2B). Because of the limited number of events, adjusted covariates included only age, sex, and RA size. Two-sided significance testing was used for all statistical tests, with a P value <0.05 considered statistically significant. Analyses were performed using SAS software version 9.4 (SAS Institute, Cary, NC). F.A., S.R., and Z.S. take responsibility for the raw data. L.K.S. takes responsibility for the statistical analyses.
RESULTS
A total of 101 subjects were enrolled. One subject withdrew from the study, 2 were found to not have PAH, and 31 were excluded because of having different causes of PH. Study results are based on 63 patients with significant precapillary PH. Of those patients, 56 were World Health Organization group 1 and 7 were World Health Organization group 4.
Results for the total patient population were also generated (n=92), which included patients with combined pre-and postcapillary PH. In this larger cohort, significant unadjusted relationships with outcome were observed for PLS, PACS, PEDSR, time to PLS, and time to PEDSR. After multivariable adjustment, the relationships yielded similar results to the univariable models. Results appear in Tables IA, IB , IIA, IIB, and III and Figure  IA and IB in the Data Supplement. Time to PLS Time from beginning of R wave (QRS complex) to the first strain peak wave.
Time to PSSR Time from the beginning of the R wave (QRS complex) to the first positive peak atrial strain rate wave.
Conduit Conduit PEDSR From the baseline to the first negative peak atrial SR wave.
Time to PEDSR Time from beginning of the R wave (QRS complex) to the first negative peak atrial SR wave.
Active Active PACS From the baseline to the second peak atrial strain curve wave. Corresponds to ventricular diastole.
PCSR
From the baseline to the second negative peak atrial SR wave.
Time to PACS Time from beginning of R wave (QRS complex) to the second strain peak wave.
Time to PCSR Time from beginning of the R wave (QRS complex) to the second negative peak atrial strain rate wave.
PACS indicates peak active contraction strain; PCSR, peak contraction SR; PEDSR, peak diastolic SR; PLS, peak longitudinal strain; PSSR, peak systolic SR; RA, right atrium; SR, strain rate; and STE, speckle-tracking echocardiography.
Feasibility and Reproducibility
Of the 67 study subjects with PAH, 4 were excluded from the final analysis because of inadequate image quality for STE analysis (feasibility of RA function assessment >94%), resulting in 63 patients for outcome analyses. In 20 randomly selected study subjects, all the LS and SR measurements were assessed by 2 independent readers for assessment of variability using interclass correlation analyses (interclass correlation coefficient). Good reliability was determined with interclass correlation coefficient of 0.701 for PLS and 0.656 for PACS. PSSR, PEDSR, and PCSR also had good reliability (0.653, 0.667, and 0.728, respectively). Tables 2 and 3 summarize the overall baseline clinical and laboratory characteristics stratified by median PLS and PACS. The majority of study subjects (91%) were females; more than half (73%) were white, and the mean age was 58±12 years. Consistent with the majority of the patients having significant precapillary PH, the average pulmonary vascular resistance was 10±5.4 WU. Almost half of the study subjects had at least World Health Organization functional class II symptoms, with a mean (SD) 6-minute walk distance of 372±132 m, and 87% were on PH medications, and the majority of the cohort had an abnormal PLS and PACS. 
Baseline Characteristics
RA Reservoir Function
Compared with study subjects with higher PLS values, those with PLS values ≤25% had a higher proportion of females (97% versus 83%); however, this difference was not statistically significant. Study subjects with lower PLS also had worse global and regional RV function as assessed by global longitudinal strain and tricuspid annular plane systolic excursion (both P<0.001). Differences with other echocardiographic variables were observed. Stratified PLS results are provided in Table 4 .
RA Active Contraction Function
Compared with subjects with higher PACS values, those with PACS values ≤13 were more likely to be female (P=0.007) and had significantly lower tricuspid annular plane systolic excursion (P=0.003) than study subjects with higher PACS. Differences with other echocardiographic parameters were observed. Stratified PACS results are provided in Table 5 .
RA Reservoir, Conduit, and Active Contraction Functions and Outcomes
During the follow-up period (mean: 36, median: 44, range: 1-58 months), two-thirds of the cohort (n=39, 62%) were hospitalized or had died. A total of 24 patients expired, 15 of these were preceded with a hospitalization. (Figure 2A and 2B ). PAH indicates pulmonary arterial hypertension; PH, pulmonary hypertension; PLS, peak longitudinal strain; PVR, pulmonary vascular resistance; Q, quartile; RA, right atrium; and WHO, World Health Organization. RA function variables were examined in the multivariable setting, adjusting for age, sex, and RA area. In this setting, both PLS and PACS retained their significant association with time to death or rehospitalization, P=0.0005 and P=0.0167, respectively. In the subset with complete PEDSR data (n=42), the association with PEDSR was significant, adjusted for age and sex. In the adjusted setting, an HR of 1.395 (CI, 1.158-1.681) was observed for PLS (HR for 5-U decrease) and an HR of 1.135 (CI, 1.023-1.260) for PACS (1-U decrease). The adjusted HR for PED-SR was 1.210 (CI, 1.058-1.384), reflecting the change in risk for a 0.1-U drop in PEDSR.
DISCUSSION
In this prospective observational study, we found that RA dysfunction, as assessed by RA reservoir, conduit, and active contraction, is an independent predictor of mortality and hospitalizations in PH. Both active contraction (PACS) and passive conduit function (PEDSR) were associated with outcomes. The early part of ventricular diastole is when passive filling of the ventricle occurs, dependent on RV relaxation properties 11 without active energy expenditure by the atria. 6 PH can increase RV diastolic pressure and thus create an unfavorable RA-RV pressure gradient. Changes in these parameters may be seen or perhaps be prognostic in early stages of PH where RV diastolic dysfunction may precede systolic dysfunction. In late diastole, the RA behaves like a pump: RA pressure rises because of active atrial contraction, coinciding with the P wave on the EKG, and pushes the blood through the tricuspid valve toward the RV. 6 In early disease stages, the RA active contraction increases, likely as a compensatory mechanism for the reduced reservoir and passive conduit function. 12 As RV dysfunction progresses because of RV pressure overload, the preload reserve responds by the Frank-Starling mechanism and the RA compensates for ventricular dysfunction to maintain cardiac output by augmentation of RA active contraction function. However, when RV pressure overload progresses further and the preload reserve reaches its limit, RA compensation for the increased RV afterload is lost, leading to a decrease of cardiac output with the onset of severe RV failure and rapid deterioration until death occurs. 13 We evaluated RA reservoir function using both LS and SR, and we showed that study subjects with lower PLS values had significantly lower event-free survival than those with higher values. The RA serves as a reservoir for systemic venous return when the tricuspid valve is closed, reflecting diastolic dysfunction of the RV. 6 In patients with RV hypertrophy, such as in PH, the forceful RV contraction leads to an increased downward displacement of the tricuspid valve annulus, thereby increasing atrial filling as a compensatory mechanism in early disease stages; however, because of chronic elevation in RV pressure, the RA wall is often stretched. Our study supports an important role of RA reservoir function in PAH, similar to that observed in other disease states. Padeletti et al 14 demonstrated that RA PLS significantly correlated with pulmonary pressure and that RA PLS could predict PH in patients with HF. Gaynor et al 15 reported that chronic RV pressure overload did not change RV systolic function, but worsened RV diastolic function, whereas the RA became more distensible, which contributed to maintain RV filling of the stiffened ventricle. This compensatory adaptation of the RA would postpone clinical failure in patients with chronic PH. 15 Recently, a retrospective study of 37 patients with PAH found that reduced RA STE was associated with abnormal hemodynamics and adverse clinical outcomes analyses. 16 The present prospective study establishes the prognostic utility of RA function in this patient group. Future studies are indicated to investigate longitudinal, serial measurements of RA strain with disease-specific therapy and determine whether improved RA function contributes to meaningful clinical recovery. The median value of PACS is 12.5, (which is not technically the median, but a rounded up version of the median). There is 1 patient with 12.5, 1 patient with 12.8, and 1 patient with 13 for PACS. PACS indicates peak active contraction strain; PAH, pulmonary arterial hypertension; PH, pulmonary hypertension; PLS, peak longitudinal strain; Q, quartile; and WHO, World Health Organization. FAC indicates fractional area change; GLS, global longitudinal strain; LV, left ventricle; PACS, peak active contraction strain; PAH, pulmonary arterial hypertension; PCSR, peak contraction strain rate; PEDSR, peak diastolic strain rate; PLS, peak longitudinal strain; PSSR, peak systolic strain rate; RV, right ventricle; and TAPSE, tricuspid annular plane systolic excursion. The median value of PACS is 12.5, (which is not technically the median, but a rounded up version of the median). There is 1 patient with 12.5, 1 patient with 12.8, and 1 patient with 13 for PACS. FAC indicates fractional area change; GLS, global longitudinal strain; LV, left ventricle; PACS, peak active contraction strain; PAH, pulmonary arterial hypertension; PCSR, peak contraction strain rate; PEDSR, peak diastolic strain rate; PLS, peak longitudinal strain; PSSR, peak systolic strain rate; RA, right atrium; RV, right ventricle; and TAPSE, Tricuspid annular plane systolic excursion. 
Strengths and Limitations
The strengths of the study include the prospective and standardized recruitment of PH study subjects, the number of subjects included in the final analysis (with high feasibility of STE), and the assessment of reproducibility. This study also used a dedicated RA-oriented vendor-independent module. In addition, this is one of the first studies on RA function with outcomes independent of clinical variables and RA size in study subjects with PH. Limitations include that the results are from a single-center study. Another limitation is that the software package measures strain and SR at the endocardium with a lack of normative values to compare to previous studies that used left ventricular strain packages. Because of this lack of normative values, we chose a threshold for comparison of strain values as the median of the observed RA strains in this population. Also, a single-plane algorithm underestimates RA and RV volumes compared with 3-dimensional transthoracic echocardiography. Last, the possibility of a type I error exists when performing a large number of statistical tests on a small number of subjects.
Conclusions
We found that evaluating RA function with strain was feasible and that RA dysfunction was associated with lower event-free survival in a cohort of patients with PAH. RA reservoir, conduit, and active contraction functions were independent predictors of mortality and hospitalizations in PAH. Given these findings, RA STE may be a useful tool to risk stratify patients with PAH.
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